About
BrainKey
Neuroscientists built BrainKey to ensure a healthier future for the world’s most complex organ - the human brain.
BrainKey's long-term mission is to unlock better future treatments for the 1+ billion people suffering from debilitating neurological and other brain disorders.
Leadership Team
Founder & CEO
“My mom had a treatable form of dementia that went undiagnosed for years, leading to a worse outcome than it should have. This experience drives us at BrainKey, a company dedicated to transforming how we identify, treat, and manage brain health.
At BrainKey, we’re harnessing the power of AI and advanced clinical technologies to provide personalized brain health insights through brain MRI and biomedical analysis. Our mission is clear: to equip physicians with the tools they need to prevent cognitive decline and create a world where dementia no longer threatens 1 in 3 of us.
This mission is deeply personal to me, but it’s also a global challenge—one we’re determined to solve.”
Shiwen (Valerie) Wang
Katharina Koch, PhD
Natalia Del Campo, PhD
Nathan Strong, PhD
Kevin Aquino, PhD
William Ogden Moore
Daniel J. Valentino, PhD
Alyssa Goulding
Brittany Holmes, PhD
Owen Philips, PhD
Trusted Advisors
Maximilian Ibel, PhD
Board Member
Professor Akshay Chaudhari, PhD
Stanford University
Professor James Cole, PhD
University College London
Professor Olivier Rascol, MD, PhD
University of Toulouse
Edmond Knopp, MD
Neuroradiology
Proudly Backed by
